Arcadia Biosciences

Quarterly Financials

Values in thousands2025-12-312025-09-302025-06-302025-03-31
Revenue
$901
$1,302
$1,455
$1,200
Gross Profit
193
418
631
518
EBITDA
-1,377
858
-1,486
-1,207
EBIT
856
-1,501
-1,220
Net Income
-1,336
856
-4,458
2,599
Net Change In Cash
901
1,302
1,455
1,200
Free Cash Flow
-861
-257
-2,033
-1,588
Cash
259
1,120
1,376
3,159
Basic Shares
1,368
1,371
1,367
1,366

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$4,858
$5,045
$4,454
$7,418
Gross Profit
1,760
2,082
2,280
1,317
EBITDA
-2,500
-7,499
-5,731
-14,749
EBIT
-7,612
-6,018
-15,228
Net Income
-2,339
-7,038
-13,981
-15,376
Net Change In Cash
4,858
5,045
4,454
7,418
Free Cash Flow
-4,739
-9,643
-15,299
-14,049
Cash
259
4,242
6,518
20,644
Basic Shares
1,368
1,363
1,236
599

Earnings Calls

QuarterEPS
2025-09-30
$0.62
2025-06-30
-$3.26
2025-03-31
$1.90
2024-12-31
-$2.99